Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer

Published:2015-08 Issue:8 Volume:33 Page:337.e1-337.e6
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Rajan Prabhakar,Frew John A.,Wilson James M.,Azzabi Ashraf S.T.,McMenemin Rhona M.,Stockley Jacqueline,Soomro Naeem A.,Durkan Garrett,Pedley Ian D.,Leung Hing Y.

Funder

Sanofi-Aventis

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation;Dowlati;Clin Cancer Res,2001

2. Prioritizing targets for precision cancer medicine;Andre;Ann Oncol,2014

3. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer;Mottet;Eur Urol,2011

4. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

5. Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms;Omlin;Eur Urol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy;Current Medical Research and Opinion;2018-03-27

2. Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis;PLOS ONE;2016-06-16

3. Combined Chemohormonal Strategy in Hormone-Sensitive Prostate Cancer: A Pooled Analysis of Randomized Studies;Clinical Genitourinary Cancer;2016-06

4. Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells;Advances in Biological Regulation;2016-01